Net Income (Quarterly) Chart

Historical Net Income (Quarterly) Data

View and export this data back to 2012. Upgrade now.
Date Value
September 30, 2024 -44.38M
June 30, 2024 -56.30M
March 31, 2024 -65.62M
December 31, 2023 -73.21M
September 30, 2023 -89.57M
June 30, 2023 -68.47M
March 31, 2023 -77.23M
December 31, 2022 6.807M
September 30, 2022 -47.86M
June 30, 2022 -39.06M
March 31, 2022 -46.68M
December 31, 2021 8.208M
September 30, 2021 -36.53M
June 30, 2021 399.47M
March 31, 2021 -41.56M
December 31, 2020 -0.699M
September 30, 2020 -53.78M
June 30, 2020 -42.55M
March 31, 2020 -28.00M
December 31, 2019 -41.43M
September 30, 2019 -23.60M
June 30, 2019 -31.40M
March 31, 2019 -27.77M
December 31, 2018 -21.89M
Date Value
September 30, 2018 -22.04M
June 30, 2018 -20.59M
March 31, 2018 -18.79M
December 31, 2017 -27.47M
September 30, 2017 -10.24M
June 30, 2017 -21.27M
March 31, 2017 -20.27M
December 31, 2016 -14.72M
September 30, 2016 -15.27M
June 30, 2016 -21.08M
March 31, 2016 -22.30M
December 31, 2015 -17.53M
September 30, 2015 -29.08M
June 30, 2015 -21.18M
March 31, 2015 -13.69M
December 31, 2014 -16.94M
September 30, 2014 -11.50M
June 30, 2014 -12.26M
March 31, 2014 -10.77M
December 31, 2013 -10.04M
September 30, 2013 -9.497M
June 30, 2013 -10.13M
March 31, 2013 -6.632M
December 31, 2012 -6.078M

Net Income Definition

Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.

Read full definition.

Net Income (Quarterly) Range, Past 5 Years

-89.57M
Minimum
Sep 2023
399.47M
Maximum
Jun 2021
-21.92M
Average
-43.46M
Median

Net Income (Quarterly) Benchmarks

ProQR Therapeutics NV -8.917M
Merus NV -99.90M
argenx SE 91.41M
Pharming Group -1.034M
Pharvaris NV -45.87M